Troubled Spanish pharma company Grifols says it may go private for $6 billion

Shares of Grifols were halted on Monday, following news the indebted Spanish blood plasma pharmaceutical company may go private.

Previous post Oil prices move lower as Israel-Hamas cease-fire talks ease supply worries
Next post Vista Outdoor rejects MNC Capital’s bid for company, backs CSG’s offer for ammunition business